Definition according to GVP Annex I (Rev 3):
An untoward occurrence for which there is adequate evidence of an association with the medicinal product of interest. Explanatory wording provided in GVP module V (Rev 2): Undesirable clinical outcomes for which there is sufficient scientific evidence that they are caused by the medicinal product.
